I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Outcomes of pirtobrutinib for relapsed/refractory mantle ce..:
Aydilek, Enver
;
Wulf, Gerald
;
Schwarz, Friedrich
...
Cancer Medicine. 13 (2024) 10 - p. , 2024
Link:
https://doi.org/10.1002/cam4.7289
RT Journal T1
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe
UL https://suche.suub.uni-bremen.de/peid=cr-10.1002_cam4.7289&Exemplar=1&LAN=DE A1 Aydilek, Enver A1 Wulf, Gerald A1 Schwarz, Friedrich A1 Bacher, Ulrike A1 Rummel, Mathias A1 Stiefel, Olga A1 Kerkhoff, Andrea A1 Maulhardt, Markus A1 Melchardt, Thomas A1 Pabst, Thomas A1 Lenz, Georg A1 Shumilov, Evgenii PB Wiley YR 2024 SN 2045-7634 SN 2045-7634 JF Cancer Medicine VO 13 IS 10 LK http://dx.doi.org/https://doi.org/10.1002/cam4.7289 DO https://doi.org/10.1002/cam4.7289 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)